Literature DB >> 15972481

Intranasal administration of recombinant Neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in mice.

Gregory A Price1, Michael W Russell, Cynthia Nau Cornelissen.   

Abstract

The transferrin binding proteins (TbpA and TbpB) comprise the gonococcal transferrin receptor and are considered potential antigens for inclusion in a vaccine against Neisseria gonorrhoeae. Intranasal (IN) immunization has shown promise in development of immunity against sexually transmitted disease pathogens, in part due to the induction of antigen-specific genital tract immunoglobulin A (IgA) and IgG. Conjugation of antigens to the highly immunogenic cholera toxin B subunit (Ctb) enhances antibody responses in the serum and mucosal secretions following IN vaccination. In the current study, we characterized the anti-Tbp immune responses following immunization of mice IN with recombinant transferrin binding proteins (rTbpA and rTbpB) conjugated to rCtb. We found that both rTbpA-Ctb and rTbpB-Ctb conjugates administered IN induced antibody responses in the serum and genital tract. IN immunization resulted in both IgA and IgG in the genital tract; however, subcutaneous immunization mainly generated IgG. Surprisingly, rTbpA alone was immunogenic and induced serum and mucosal antibody responses similar to those elicited against the rTbpA-Ctb conjugate. Overall, rTbpB was much more immunogenic than rTbpA, generating serum IgG levels that were greater than those elicited against rTbpA. Bactericidal assays conducted with sera collected from mice immunized IN with TbpA and/or TbpB indicated that both antigens generated antibodies with bactericidal activity. Anti-TbpA antibodies were cross-bactericidal against heterologous gonococcal strains, whereas TbpB-specific antibodies were less cross-reactive. By contrast, antibodies elicited via subcutaneous immunization were not cross-bactericidal against heterologous strains, indicating that IN vaccination could be the preferred route for elicitation of biologically functional antibodies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15972481      PMCID: PMC1168620          DOI: 10.1128/IAI.73.7.3945-3953.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

Review 1.  Solubilization of membranes by detergents.

Authors:  A Helenius; K Simons
Journal:  Biochim Biophys Acta       Date:  1975-03-25

Review 2.  Humoral immune responses to microbial infections in the genital tract.

Authors:  Michael W Russell; Jiri Mestecky
Journal:  Microbes Infect       Date:  2002-05       Impact factor: 2.700

3.  Immunogenicity of gonococcal transferrin binding proteins during natural infections.

Authors:  Gregory A Price; Marcia M Hobbs; Cynthia Nau Cornelissen
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

4.  Mutual inhibition of the insulin absorption-enhancing properties of dodecylmaltoside and dimethyl-beta-cyclodextrin following nasal administration.

Authors:  F Ahsan; J J Arnold; E Meezan; D J Pillion
Journal:  Pharm Res       Date:  2001-05       Impact factor: 4.200

5.  Gonococcal vaccine studies in Inuvik.

Authors:  L Greenberg; B B Diena; F A Ashton; R Wallace; C P Kenny; R Znamirowski; H Ferrari; J Atkinson
Journal:  Can J Public Health       Date:  1974 Jan-Feb

6.  Asymptomatic sexually transmitted diseases: the case for screening.

Authors:  Thomas A Farley; Deborah A Cohen; Whitney Elkins
Journal:  Prev Med       Date:  2003-04       Impact factor: 4.018

7.  The presence of complement in human cervical mucus and its possible relevance to infertility in women with complement-dependent sperm-immobilizing antibodies.

Authors:  R J Price; B Boettcher
Journal:  Fertil Steril       Date:  1979-07       Impact factor: 7.329

8.  Restored functional immunogenicity of purified meningococcal PorA by incorporation into liposomes.

Authors:  Carmen Arigita; Gideon F A Kersten; Ton Hazendonk; Wim E Hennink; Daan J A Crommelin; Wim Jiskoot
Journal:  Vaccine       Date:  2003-02-14       Impact factor: 3.641

9.  NEISSERIA GONORRHOEAE. I. VIRULENCE GENETICALLY LINKED TO CLONAL VARIATION.

Authors:  D S KELLOGG; W L PEACOCK; W E DEACON; L BROWN; D I PIRKLE
Journal:  J Bacteriol       Date:  1963-06       Impact factor: 3.490

10.  Demonstration and characterization of a specific interaction between gonococcal transferrin binding protein A and TonB.

Authors:  Christopher D Kenney; Cynthia Nau Cornelissen
Journal:  J Bacteriol       Date:  2002-11       Impact factor: 3.490

View more
  26 in total

1.  Immune responses elicited in mice with recombinant Lactococcus lactis expressing F4 fimbrial adhesin FaeG by oral immunization.

Authors:  Shujie Liu; Yongming Li; Ziwei Xu; Yicheng Wang
Journal:  Vet Res Commun       Date:  2010-06-09       Impact factor: 2.459

2.  Beyond the Crystal Structure: Insight into the Function and Vaccine Potential of TbpA Expressed by Neisseria gonorrhoeae.

Authors:  Devin R Cash; Nicholas Noinaj; Susan K Buchanan; Cynthia Nau Cornelissen
Journal:  Infect Immun       Date:  2015-09-08       Impact factor: 3.441

3.  Identification of TbpA residues required for transferrin-iron utilization by Neisseria gonorrhoeae.

Authors:  Jennifer M Noto; Cynthia Nau Cornelissen
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

4.  Gonococcal transferrin binding protein chimeras induce bactericidal and growth inhibitory antibodies in mice.

Authors:  Gregory A Price; Heather P Masri; Aimee M Hollander; Michael W Russell; Cynthia Nau Cornelissen
Journal:  Vaccine       Date:  2007-08-06       Impact factor: 3.641

Review 5.  Identification and characterization of gonococcal iron transport systems as potential vaccine antigens.

Authors:  C N Cornelissen
Journal:  Future Microbiol       Date:  2008-06       Impact factor: 3.165

6.  Vaccines against gonorrhea: current status and future challenges.

Authors:  Ann E Jerse; Margaret C Bash; Michael W Russell
Journal:  Vaccine       Date:  2013-09-06       Impact factor: 3.641

7.  Neisseria gonorrhoeae NspA induces specific bactericidal and opsonic antibodies in mice.

Authors:  Guocai Li; Hongmei Jiao; Guihua Jiang; Jing Wang; Litian Zhu; Rushan Xie; Hua Yan; Hongju Chen; Mingchun Ji
Journal:  Clin Vaccine Immunol       Date:  2011-09-14

8.  Immunogenicity of a Staphylococcus aureus-cholera toxin A2/B vaccine for bovine mastitis.

Authors:  N Misra; T F Wines; C L Knopp; R Hermann; L Bond; B Mitchell; M A McGuire; J K Tinker
Journal:  Vaccine       Date:  2018-05-05       Impact factor: 3.641

Review 9.  Subversion of nutritional immunity by the pathogenic Neisseriae.

Authors:  Cynthia Nau Cornelissen
Journal:  Pathog Dis       Date:  2018-02-01       Impact factor: 3.166

10.  Vaccination of mice with gonococcal TbpB expressed in vivo from Venezuelan equine encephalitis viral replicon particles.

Authors:  Christopher E Thomas; Weiyan Zhu; Cornelius N Van Dam; Nancy L Davis; Robert E Johnston; P Frederick Sparling
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.